2020
DOI: 10.1007/s13691-020-00433-3
|View full text |Cite
|
Sign up to set email alerts
|

A long-term survival case of unresectable gastric cancer with multidisciplinary therapy including immunotherapy and abscopal effect

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 22 publications
0
11
0
Order By: Relevance
“…Nevertheless, LN status remains the most valid prognostic factor of survival after neoadjuvant therapy and gastrectomy. The addition of RT by its Abscopal effect [34,77] results in less adequate detection of LN in histopathological examination [34].…”
Section: Status Of Radio-and Radiochemo-therapy In Perioperative Settingmentioning
confidence: 99%
“…Nevertheless, LN status remains the most valid prognostic factor of survival after neoadjuvant therapy and gastrectomy. The addition of RT by its Abscopal effect [34,77] results in less adequate detection of LN in histopathological examination [34].…”
Section: Status Of Radio-and Radiochemo-therapy In Perioperative Settingmentioning
confidence: 99%
“…However, the clinical indications and prognostic significance of surgery after treatment with nivolumab remain obscure ( 24 ). Some studies have shown that for AGC patients with distant metastasis, only gastrectomy and lymph node dissection were performed, and then CR was observed after chemotherapy ( 25 ). Moreover, the median survival time of the operation group was significantly longer than that of the non-operation group ( 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is important to bear in mind that in 2018 a consensus about CRS-HIPEC in PM was published in which the authors agreed that for GC a prospective randomized trial is needed and that patients with PM from GC should be considered for clinical trials [41,42]. There are several case reports and studies showing the benefit of multimodality therapy including immunotherapy [43,44]. Therefore, multidisciplinary treatment of unresectable gastric cancer is believed to be essential to improve patient outcomes.…”
Section: Current Practicementioning
confidence: 99%